Key Points
- Director Susan Elizabeth Knight bought 11,000 shares of Anteris Technologies Global on June 2 at an average price of $9.29, totaling $102,190. After the purchase, she owned 11,000 shares directly.
- Anteris Technologies Global stock recently traded near $9.65, close to its 52-week high of $10.14, with a market value of about $939.3 million. The company remains unprofitable, with recent quarterly EPS of -$0.28 and revenue below analyst expectations.
- Wall Street sentiment is mixed but generally constructive, with an average rating of Moderate Buy and a consensus price target of $16.00. Analysts currently include several Buy/Overweight ratings, though one firm maintains a sell rating.
Anteris Technologies Global Corp. (NASDAQ:AVR - Get Free Report) Director Susan Elizabeth Knight purchased 11,000 shares of the firm's stock in a transaction on Tuesday, June 2nd. The shares were acquired at an average cost of $9.29 per share, for a total transaction of $102,190.00. Following the completion of the purchase, the director directly owned 11,000 shares of the company's stock, valued at approximately $102,190. This represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Anteris Technologies Global Stock Performance
Shares of Anteris Technologies Global stock opened at $9.65 on Friday. Anteris Technologies Global Corp. has a 52-week low of $2.85 and a 52-week high of $10.14. The stock has a market capitalization of $939.33 million, a price-to-earnings ratio of -4.33 and a beta of 1.78. The company has a fifty day moving average of $6.74 and a 200-day moving average of $5.83.
Anteris Technologies Global (NASDAQ:AVR - Get Free Report) last issued its earnings results on Tuesday, May 12th. The company reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.27) by ($0.01). The business had revenue of $0.49 million during the quarter, compared to analysts' expectations of $0.77 million. Anteris Technologies Global had a negative return on equity of 124.76% and a negative net margin of 5,148.78%.During the same quarter in the previous year, the business earned ($0.61) EPS. On average, equities research analysts forecast that Anteris Technologies Global Corp. will post -1.14 earnings per share for the current fiscal year.
Institutional Trading of Anteris Technologies Global
Institutional investors and hedge funds have recently bought and sold shares of the stock. Deutsche Bank AG increased its stake in shares of Anteris Technologies Global by 8.1% during the fourth quarter. Deutsche Bank AG now owns 28,865 shares of the company's stock valued at $144,000 after purchasing an additional 2,171 shares in the last quarter. Bank of America Corp DE increased its stake in shares of Anteris Technologies Global by 35.7% during the third quarter. Bank of America Corp DE now owns 10,631 shares of the company's stock valued at $48,000 after purchasing an additional 2,798 shares in the last quarter. Russell Investments Group Ltd. increased its stake in shares of Anteris Technologies Global by 76.9% during the third quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company's stock valued at $29,000 after purchasing an additional 2,841 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Anteris Technologies Global by 35.2% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,744 shares of the company's stock valued at $45,000 after purchasing an additional 3,055 shares in the last quarter. Finally, Barclays PLC increased its stake in shares of Anteris Technologies Global by 3.0% during the fourth quarter. Barclays PLC now owns 148,128 shares of the company's stock valued at $739,000 after purchasing an additional 4,289 shares in the last quarter.
Wall Street Analysts Forecast Growth
AVR has been the topic of a number of recent research reports. Wall Street Zen raised Anteris Technologies Global from a "sell" rating to a "hold" rating in a research note on Saturday, May 16th. Barclays raised their price objective on Anteris Technologies Global from $17.00 to $18.00 and gave the company an "overweight" rating in a research note on Friday, May 15th. Wells Fargo & Company initiated coverage on Anteris Technologies Global in a research note on Wednesday, March 11th. They set an "overweight" rating and a $16.00 price objective on the stock. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Anteris Technologies Global in a research note on Friday, May 29th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and set a $15.00 price objective on shares of Anteris Technologies Global in a research note on Friday, March 27th. Four investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $16.00.
Read Our Latest Report on Anteris Technologies Global
About Anteris Technologies Global
(
Get Free Report)
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
